LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering MoonLake Immunotherapeutics (MLTX) Q4 25 Estimate To -0.50 From -0.18 11/4/2024 5:18:21 PM
  • Wedbush Is Lowering MoonLake Immunotherapeutics (MLTX) Q3 25 Estimate To -0.48 From -0.17 11/4/2024 5:17:39 PM
  • Wedbush Is Cutting MoonLake Immunotherapeutics (MLTX) Q2 25 Estimate To -0.46 From -0.17 11/4/2024 5:17:28 PM
  • Wedbush Is Cutting MoonLake Immunotherapeutics (MLTX) Q1 25 Estimate To -0.42 From -0.17 11/4/2024 5:17:08 PM
  • Wedbush Is Cutting MoonLake Immunotherapeutics (MLTX) FY24 Estimate To -1.33 From -0.65 11/4/2024 5:16:54 PM
  • Wedbush Is Lowering MoonLake Immunotherapeutics (MLTX) Q4 24 Estimate To -0.38 From -0.17 11/4/2024 5:16:35 PM
  • Wedbush Reiterates MoonLake Immunotherapeutics (MLTX) At Outperform With $92 Price Target 3/13/2024 9:48:26 AM
  • Wedbush Reiterates MoonLake Immunotherapeutics (MLTX) At Outperform With $92 Price Target 3/11/2024 10:32:56 AM
  • William Blair Reiterates MoonLake Immunotherapeutics (MLTX) At Outperform With $92 Price Target 2/26/2024 5:17:00 PM
  • MoonLake Gets Positive FDA, EMA Feedback For Sonelokimab Phase 3 Program In Hidradenitis Suppurativa 2/26/2024 8:16:44 AM
  • Wedbush Is Raising MoonLake Immunotherapeutics (MLTX) FY23 Estimate To -0.80 From -0.81 11/16/2023 4:50:13 PM
  • Wedbush Is Increasing MoonLake Immunotherapeutics (MLTX) Q4 23 Estimate To -0.15 From -0.17 11/16/2023 4:49:59 PM
  • Wedbush Reiterates MoonLake Immunotherapeutics (MLTX) At Outperform With $92 Up From $86 Price Target 11/16/2023 4:49:31 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap